国际麻醉学与复苏杂志   2022, Issue (8): 0-0
    
氟比洛芬酯不同时机给药对结肠癌根治术患者 术后免疫功能的影响
王行何, 李童, 郭科迪, 李笑笑, 杨玉萍, 刘苏1()
1.徐州医科大学附属医院麻醉科
Effect of different administration time of flurbiprofen axetil on the immune function of patients undergoing radical resection of colon cancer
 全文:
摘要:

目的 探讨术中氟比洛芬酯(flurbiprofen axetil, FA)不同时机给药对结肠癌根治术患者术后免疫功能的影响。 方法 选择124例择期于全身麻醉下行腹腔镜结肠癌根治术的患者,按随机数字表法分为4组(每组31例):术前给药组(Pre组)、术中给药组(Intra组)、术毕给药组(Post组)、对照组(Control组)。4组麻醉在其他用药相同基础上,Pre组麻醉诱导前10 min缓慢静脉注射FA 100 mg,Intra组气腹建立1 h后缓慢静脉注射FA 100 mg,Post组缝皮结束后缓慢静脉注射FA 100 mg,Control组不使用FA。收集患者人口学特征、手术相关基本信息及术中情况,记录患者麻醉诱导前15 min(T0)、术后24 h(T2)、术后48 h(T3)、术后72 h(T4)时外周血CD4+水平、CD4+/CD8+、TNF‑α水平、IL‑6水平,记录患者术毕(T1)、T2、T3、T4时的VAS疼痛评分,记录患者术后并发症发生情况、术后1年肿瘤复发情况及总体生存率。 结果 Pre组、Intra组瑞芬太尼用量少于Post组和Control组(P<0.05)。T0时4组患者CD4+水平、CD4+/CD8+、TNF‑α水平、IL‑6水平比较,差异均无统计学意义(P>0.05)。与T0比较:T2时4组患者CD4+水平、CD4+/CD8+降低(P<0.05),T2~T4时4组患者TNF‑α、IL‑6水平均升高(P<0.05)。与Control组比较:T2时Pre组、Intra组、Post组,T3时Pre组、Intra组,T4时Pre组CD4+水平升高(P<0.05);T2、T3时Pre组、Intra组,T4时Pre组CD4+/CD8+升高(P<0.05);T2、T3时Pre组、Intra组、Post组,T4时Pre组、Intra组TNF‑α水平降低(P<0.05);T2、T4时Pre组、Intra组、Post组,T3时Pre组、Intra组IL‑6水平降低(P<0.05)。与Post组比较:T3、T4时Pre组CD4+水平升高,T4时Pre组IL‑6水平降低(P<0.05)。与Intra组比较:T4时Pre组CD4+水平、CD4+/CD8+升高(P<0.05)。T1时Pre组、Intra组、Post组静息及咳嗽VAS疼痛评分均低于Control组(P<0.05)。4组患者术后并发症发生情况差异均无统计学意义(P>0.05)。Pre组、Control组各有1例提示存在肿瘤复发,1年内各组均无死亡病例,4组差异无统计学意义(P>0.05)。 结论 术前静脉注射FA对结肠癌根治术患者术后免疫功能具有保护作用,效果优于术中及术毕给药。

关键词: 氟比洛芬酯; 结肠癌; 免疫功能; CD4+; CD4+/CD8+
Abstract:

Objective To investigate the effect of different administration time of flurbiprofen axetil (FA) on postoperative immune function of patients undergoing radical resection of colon cancer. Methods A total of 124 patients who were scheduled for laparoscopic resection of colon cancer under general anesthesia were selected. According to the random number table method, they were divided into four groups (n=31): a preoperative administration group (group Pre), an intraoperative administration group (group Intra), a postoperative administration group (group Post) and a control group (group Control). On the basis of the same other anesthetics in the 4 groups, group Pre was slowly intravenously injected with FA 100 mg 10 min before induction of anaesthesia, group Intra was slowly intravenously injected with FA 100 mg 1 h after the establishment of the pneumoperitoneum, group Post was slowly intravenously injected with FA 100 mg at the end of suturing, and group Control did not administered with FA. Collect patient demographic characteristics, surgery‑related information, and intraoperative conditions. The levels of CD4+, CD4+/CD8+, tumor necrosis factor‑α (TNF⁃α) and interleukin‑6 (IL⁃6) in peripheral blood were recorded 15 min before induction of anesthesia (T0), 24 h after surgery (T2), 48 h after surgery (T3) and 72 h after surgery (T4). Their Visual Analogue Scale (VAS) scores at the end of surgery (T1), T2, T3 and T4 were recorded. The postoperative complications, tumor recurrence‑free and overall survival rate 1 year after surgery were also recorded. Results The amounts of remifentanil used in groups Pre and Intra were less than those in groups Post and Control (P<0.05). There was no statistical difference in the levels of CD4+, CD4+/CD8+, TNF⁃α and IL⁃6 at T0 in the four groups (P>0.05). Compared with those at T0: the four groups presented decreases in the levels of CD4+ and CD4+/CD8+ at T2 (P<0.05), increases in TNF‑α and IL‑6 at T2 to T4 (P<0.05). Compared with those in group Control: the levels of CD4+ increased at T2 in group Pre, Intra and Post, increased at T3 in group Pre and Intra, increased at T4 in group Pre (P<0.05); the ratio of CD4+/CD8+ increased at T2 and T3 in group Pre and Intra, increased at T4 in group Pre (P<0.05); the levels of TNF‑α decreased at T2 and T3 in group Pre, Intra and Post, decreased at T4 in group Pre and Intra (P<0.05); the levels of IL‑6 decreased at T2 and T4 in group Pre, Intra and Post, decreased at T3 in group Pre and Intra (P<0.05). Compared with group Post: the levels of CD4+ increased at T3 and T4 in group Pre, the levels of IL‑6 decreased at T4 in group Pre (P<0.05). Compared with group Intra: the levels of CD4+ and CD4+/CD8+ increased at T4 in group Pre (P<0.05). The rest and coughing VAS scores in group Pre, Intra and Post were lower than group Control at T1 (P<0.05). There was no significant difference in postoperative complications between the four groups (P>0.05). There was one case of tumor recurrence in each of group Pre and group Control, and there was no death in each group within one year, there was no significant difference between the two groups (P>0.05). Conclusion Preoperative intravenous FA has a protective effect on the immune function of patients undergoing radical resection of colon cancer, which is better than intraoperative and postoperative administration.

Key words: lurbiprofen axetil; Colon cancer; Immune function; CD4+; CD4+/CD8+